About Ritelth Medipharma Private Limited
Data last updated:
Ritelth Medipharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2016PTC272679. Its GSTIN is 27AAKCM1792J1Z0 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It was formerly known as Merk Medipharma Private Limited. It is led by directors including Hemant Sajanrao Shewale and Balasaheb Tukaram Mohite.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No.101 Madhupushpa Chs Near Bramhan Vidyalaya Charai Thane We, St, Maharashtra, India – 400601.
As per the financials filed for FY 2023, the company reported a revenue of ₹21,088, a decline of 49% compared to the previous year. For the same year it recorded a net loss of ₹1.97 Lakh and EBITDA of ₹21,088 (EBITDA margin 100%). Revenue has declined at a compounded annual rate (CAGR) of 88% over three years and 72% over five years.
The company is associated with 1 brand: Ritelth. As per MCA filings, the company has open charges of ₹20 Lakh and satisfied charges of ₹20 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ritelth.com.
Company details
CIN history
Ritelth Medipharma has one previous CIN (Corporate Identification Number): U51103MH2016PTC272679. The current CIN is U24100MH2016PTC272679, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100MH2016PTC272679 | Current |
| U51103MH2016PTC272679 | Previous |
Contact details
Ritelth Medipharma Private Limited's registered office is in Thane, Maharashtra. Its website is ritelth.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No.101 Madhupushpa Chs Near Bramhan Vidyalaya Charai Thane We, St, Maharashtra, India – 400601
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ritelth Medipharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ritelth Medipharma operates one associated brand: Ritelth. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supplying pharmaceutical medicines and drugs for domestic and international markets from India. | ritelth.com |
Financials of Ritelth Medipharma Private Limited
FY 2025 filings availableRitelth Medipharma Private Limited reported revenue of ₹21,088 (down 49% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 72% over five years, including a 49% fall in the latest year. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21,088 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 100% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ritelth Medipharma Private Limited, buy the company report.
Board of directors of Ritelth Medipharma Private Limited
Ritelth Medipharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemant Sajanrao Shewale Also directs: Neral Medico LLP | Director | 04 Feb 2016 | 10 Years 9 Months | Current |
| Balasaheb Tukaram Mohite | Director | 04 Feb 2016 | 10 Years 9 Months | Current |
| Krishna Bhaskar Nimsakhare Also directs: Bhagwati Healthcare Private Limited | Director | 04 Feb 2016 | 10 Years 9 Months | Current |
Auditor
Ritelth Medipharma Private Limited is audited by R R PINGALE & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R R PINGALE & CO | FY 2019 | 117610W |
Shareholding
The shareholding of Ritelth Medipharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ritelth Medipharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jul 2018 | 100196972 | Others | ₹20 Lakh | Satisfied |
To see the full charge records of Ritelth Medipharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ritelth Medipharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ritelth Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ritelth Medipharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCM1792J1Z0 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ritelth Medipharma Private Limited, buy the company report.
Recent activity
Ritelth Medipharma Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Balasaheb Tukaram Mohite was appointed as Director on 04 Feb 2016.
Frequently asked questions
Ritelth Medipharma is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2016 (10+ years old) and is registered under CIN U24100MH2016PTC272679.
Ritelth Medipharma has 3 current directors:
- Hemant Sajanrao Shewale - Director
- Balasaheb Tukaram Mohite - Director
- Krishna Bhaskar Nimsakhare - Director
The latest financial statements of Ritelth Medipharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Ritelth Medipharma is 27AAKCM1792J1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ritelth Medipharma is U24100MH2016PTC272679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ritelth Medipharma was incorporated on 04 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Balasaheb Tukaram Mohite was appointed as Director on 04 Feb 2016. Hemant Sajanrao Shewale was appointed as Director on 04 Feb 2016. Krishna Bhaskar Nimsakhare was appointed as Director on 04 Feb 2016.
Ritelth Medipharma can be reached through the website ritelth.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Ritelth Medipharma is at Office No.101 Madhupushpa Chs Near Bramhan Vidyalaya Charai Thane We, St, Maharashtra, India – 400601.
Ritelth Medipharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
